![Bradley Meyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bradley Meyer
Direktör/Styrelseledamot på
AVENG LIMITED
Förmögenhet: 632 327 $ per 2026-09-30
Profil
Bradley Carl Meyer is currently an Independent Non-Executive Director at Aveng Ltd. since 2021, an Independent Non-Executive Director at Santhera Pharmaceuticals Holding AG since 2023, and a Director at Quotient Ltd. since 2023.
Additionally, Mr. Meyer serves as a Director at Biocartis SA and Quotient Suisse SA. Former roles include Managing Director at Perella Weinberg Partners from 2014 to 2015, Member of the Financial Restructuring Group at Houlihan Lokey, Inc. from 2003 to 2012, and Member positions at Millstein & Co. LP and Ducera Partners LLC.
Education includes undergraduate studies at Harvard University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2025-12-31 | 34 062 ( 0,21 % ) | 632 327 $ | 2026-09-30 |
Aktiva positioner av Bradley Meyer
| Företag | Position | Start |
|---|---|---|
| AVENG LIMITED | Direktör/Styrelseledamot | 2021-05-28 |
| QUOTIENT LIMITED | Direktör/Styrelseledamot | 2023-02-16 |
| SANTHERA PHARMACEUTICALS HOLDING AG | Direktör/Styrelseledamot | 2023-06-27 |
Quotient Suisse SA
 Quotient Suisse SA BiotechnologyHealth Technology Develops transfusion diagnostics products to hospitals and blood banks | Direktör/Styrelseledamot | - |
Biocartis SA
 Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Bradley Meyer
| Företag | Position | Slut |
|---|---|---|
| PERELLA WEINBERG PARTNERS | Företagsledare/Principal | 2015-02-01 |
| HOULIHAN LOKEY, INC. | Företagsledare/Principal | 2012-01-01 |
Millstein & Co. LP
 Millstein & Co. LP Investment ManagersFinance Acts as an alternative investment manager | Företagsledare/Principal | - |
Ducera Partners LLC
 Ducera Partners LLC Regional BanksFinance Provides investment banking services | Företagsledare/Principal | - |
Bradley Meyers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
67
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aveng Ltd.
 Aveng Ltd. Engineering & ConstructionIndustrial Services Engages in infrastructure development | Industrial Services |
Houlihan Lokey, Inc.
 Houlihan Lokey, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Santhera Pharmaceuticals Holding AG
 Santhera Pharmaceuticals Holding AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for the treatment of neuromuscular diseases | Health Technology |
Biocartis SA
Biocartis SA Medical SpecialtiesHealth Technology Develops molecular diagnostic instruments for immunodiagnostics | Health Technology |
Quotient Ltd.
 Quotient Ltd. Medical SpecialtiesHealth Technology Develops and manufactures conventional reagent products | Health Technology |
Millstein & Co. LP
Millstein & Co. LP Investment ManagersFinance Acts as an alternative investment manager | Finance |
Quotient Suisse SA
Quotient Suisse SA BiotechnologyHealth Technology Develops transfusion diagnostics products to hospitals and blood banks | Health Technology |
Ducera Partners LLC
Ducera Partners LLC Regional BanksFinance Provides investment banking services | Finance |
Perella Weinberg Partners
 Perella Weinberg Partners Investment ManagersFinance Provides financial and strategic advisory services | Finance |
